Melatonin facts: Melatonin lacks immuno-inflammation boosting capacities at the molecular and cellular levels
Biochimie 2024; 222:195–202
BOUTIN J. A., HAMON DE ALMEIDA V., COUSSAY N., LEGROS C., FERRY G., REYBIER K. (2024)
Laboratory of Neuroendocrine Endocrine and Germinal Differentiation and Communication (NorDiC), University Rouen Normandie, INSERM, NorDiC UMR 1239, F-76000, Rouen, France.
Qima-Bioalternatives, Gençay, France.
Eurofins Discovery, Celle L’Evescault, France.
Gilles Ferry Consulting, St Aygulf, France.
Pharma-Dev UMR 152, Université de Toulouse, IRD, UT3, Toulouse, France.
Abstract
Among the properties melatonin is claimed to possess, are the immuno-inflammation inductive capacities that would be responsible of some of the paramount of activities melatonin is reported to have in most of the human pathological conditions. In the present paper, we measured the effect of melatonin on established cellular models of immuno-inflammation, and found none. The discrepancies are discussed, especially because those properties are reported at pharmacological concentration (1 mM and beyond) at which the melatonin receptors are desensitized by internalization, leading to putative non-receptor dependent mechanism of action.
>> Read the full article here
© The Author(s) 2024.
